• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2型感染的症状前传播:一项利用已发表数据的二次分析

Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.

作者信息

Casey-Bryars Miriam, Griffin John, McAloon Conor, Byrne Andrew, Madden Jamie, Mc Evoy David, Collins Áine, Hunt Kevin, Barber Ann, Butler Francis, Lane Elizabeth Ann, O'Brien Kirsty, Wall Patrick, Walsh Kieran, More Simon John

机构信息

Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland

Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland.

出版信息

BMJ Open. 2021 Jun 28;11(6):e041240. doi: 10.1136/bmjopen-2020-041240.

DOI:10.1136/bmjopen-2020-041240
PMID:34183334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8245290/
Abstract

OBJECTIVE

To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset.

SETTING/DESIGN: Secondary analysis of international published data.

DATA SOURCES

Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately.

PARTICIPANTS

Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020.

METHODS

Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated.

OUTCOME MEASURES

Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission.

RESULTS

Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from -2.6 (95% CI -3.0 to -2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%).

CONCLUSIONS

There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context.

摘要

目的

估计新冠病毒感染无症状传播的比例以及相对于症状出现的传播时间。

设置/设计:对国际已发表数据进行二次分析。

数据来源

对新冠病毒潜伏期的荟萃分析以及对系列间隔时间和代际时间的快速综述,二者分别发表。

参与者

2019年12月至2020年5月来自中国、伊朗伊斯兰共和国、意大利、韩国、新加坡和越南的数据。

方法

对潜伏期以及系列间隔时间或代际时间进行模拟。据此估计相对于症状出现的传播时间以及无症状传播的比例。

观察指标

新冠病毒相对于症状出现的传播时间以及无症状传播的比例。

结果

基于15篇论文中的18个系列间隔时间/代际时间估计值,相对于感染症状出现的平均传播时间范围为感染前2.6天(95%置信区间 -3.0至 -2.1)至感染症状出现后1.4天(95%置信区间1.0至1.8)。无症状传播的比例范围为45.9%(95%置信区间42.9%至49.0%)至69.1%(95%置信区间66.2%至71.9%)。

结论

在一系列不同情况下,新冠病毒无症状传播具有很大可能性。这凸显了快速病例检测、接触者追踪和隔离的必要性。我们报告的传播模式反映了生物传染性和传播机会的综合情况,而这会因情况而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/f523348fe9b9/bmjopen-2020-041240f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/c9c3e3325a95/bmjopen-2020-041240f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/802205d5a2c3/bmjopen-2020-041240f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/44b00209d84f/bmjopen-2020-041240f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/8912783fd70c/bmjopen-2020-041240f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/f523348fe9b9/bmjopen-2020-041240f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/c9c3e3325a95/bmjopen-2020-041240f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/802205d5a2c3/bmjopen-2020-041240f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/44b00209d84f/bmjopen-2020-041240f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/8912783fd70c/bmjopen-2020-041240f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5d/8245290/f523348fe9b9/bmjopen-2020-041240f05.jpg

相似文献

1
Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.新型冠状病毒2型感染的症状前传播:一项利用已发表数据的二次分析
BMJ Open. 2021 Jun 28;11(6):e041240. doi: 10.1136/bmjopen-2020-041240.
2
High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing.在 COVID-19 症状出现之前具有很高的传染性,这凸显了持续进行接触者追踪的重要性。
Elife. 2021 Apr 26;10:e65534. doi: 10.7554/eLife.65534.
3
[Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].[日本SARS-CoV-2感染个体在症状前期或无症状状态下SARS-CoV-2的传播:病例系列]
Nihon Koshu Eisei Zasshi. 2021 Aug 11;68(8):550-558. doi: 10.11236/jph.20-145. Epub 2021 May 14.
4
Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.新冠病毒(SARS-CoV-2)在出现症状前后的传播:中国非药物干预的影响。
Eur J Epidemiol. 2021 Apr;36(4):429-439. doi: 10.1007/s10654-021-00746-4. Epub 2021 Apr 21.
5
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.SARS-CoV-2 血清流行率和高危密切接触者的传播风险因素:一项回顾性队列研究。
Lancet Infect Dis. 2021 Mar;21(3):333-343. doi: 10.1016/S1473-3099(20)30833-1. Epub 2020 Nov 2.
6
Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.2020 年 1 月 23 日至 3 月 16 日新加坡出现的 SARS-CoV-2 病前传播。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415. doi: 10.15585/mmwr.mm6914e1.
7
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
8
The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam.越南对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的前 100 天控制。
Clin Infect Dis. 2021 May 4;72(9):e334-e342. doi: 10.1093/cid/ciaa1130.
9
Transmission onset distribution of COVID-19.COVID-19 的传播起始分布。
Int J Infect Dis. 2020 Oct;99:403-407. doi: 10.1016/j.ijid.2020.07.075. Epub 2020 Aug 6.
10
Epidemiological Parameters of COVID-19: Case Series Study.新型冠状病毒肺炎的流行病学参数:病例系列研究
J Med Internet Res. 2020 Oct 12;22(10):e19994. doi: 10.2196/19994.

引用本文的文献

1
Viral Transmission in Sea Food Systems: Strategies for Control and Emerging Challenges.海产品系统中的病毒传播:控制策略与新出现的挑战
Foods. 2025 Mar 20;14(6):1071. doi: 10.3390/foods14061071.
2
Molecular epidemiology of SARS-CoV-2 genome sentinel surveillance in commercial COVID-19 testing sites targeting asymptomatic individuals during Japan's seventh epidemic wave.日本第七波疫情期间,在针对无症状个体的商业 COVID-19 检测点进行的 SARS-CoV-2 基因组哨点监测的分子流行病学研究。
Sci Rep. 2024 Sep 9;14(1):20950. doi: 10.1038/s41598-024-71953-8.
3
Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes.

本文引用的文献

1
Epidemiological and Clinical Characteristics of COVID-19 in Adolescents and Young Adults.青少年和青年成人新型冠状病毒肺炎的流行病学及临床特征
Innovation (Camb). 2020 May 21;1(1):100001. doi: 10.1016/j.xinn.2020.04.001. Epub 2020 May 20.
2
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
3
Rapid review of available evidence on the serial interval and generation time of COVID-19.
呼出的 SARS-CoV-2 气溶胶具有足够的感染力,可在数分钟内传播 COVID-19。
Sci Rep. 2023 Dec 1;13(1):21245. doi: 10.1038/s41598-023-47829-8.
4
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.人类 ACE2 蛋白是一种分子开关,控制着 SARS-CoV-2 的传播模式。
J Biomed Sci. 2023 Oct 12;30(1):87. doi: 10.1186/s12929-023-00980-w.
5
Modeling and Global Sensitivity Analysis of Strategies to Mitigate Covid-19 Transmission on a Structured College Campus.基于结构化大学校园的新冠病毒传播缓解策略的建模与全局敏感性分析。
Bull Math Biol. 2023 Jan 13;85(2):13. doi: 10.1007/s11538-022-01107-2.
6
Characterization of COVID-19 cases in the early phase (March to July 2020) of the pandemic in Kenya.肯尼亚大流行早期(2020 年 3 月至 7 月)新冠病毒病例的特征描述。
J Glob Health. 2022 Dec 30;12:15001. doi: 10.7189/jogh.12.15001.
7
A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.一项关于0.4%聚维酮碘鼻喷雾剂清除鼻咽部严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的初步研究。
Infect Drug Resist. 2022 Dec 21;15:7529-7536. doi: 10.2147/IDR.S391630. eCollection 2022.
8
Contribution of Testing Strategies and Contact Tracing towards COVID-19 Outbreaks Control: A Mathematical Modeling Study.检测策略和接触者追踪对COVID-19疫情控制的贡献:一项数学建模研究
Trop Med Infect Dis. 2022 Nov 14;7(11):376. doi: 10.3390/tropicalmed7110376.
9
Transmission dynamics of monkeypox in the United Kingdom: contact tracing study.英国猴痘病毒传播动力学:接触者追踪研究。
BMJ. 2022 Nov 2;379:e073153. doi: 10.1136/bmj-2022-073153.
10
Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.需要隔离的人数和通过隔离预防的感染日比例:评估 COVID-19 接触者追踪的有效性。
Public Health Rep. 2022 Nov-Dec;137(6):1178-1186. doi: 10.1177/00333549221114343. Epub 2022 Aug 20.
对 COVID-19 的序列间隔和代时的现有证据进行快速回顾。
BMJ Open. 2020 Nov 23;10(11):e040263. doi: 10.1136/bmjopen-2020-040263.
4
Epidemiological Investigation of the First 135 COVID-19 Cases in Brunei: Implications for Surveillance, Control, and Travel Restrictions.文莱首例 135 例 COVID-19 病例的流行病学调查:对监测、控制和旅行限制的启示。
Am J Trop Med Hyg. 2020 Oct;103(4):1608-1613. doi: 10.4269/ajtmh.20-0771.
5
Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research.COVID-19 的潜伏期:一项针对观察性研究的快速系统评价和荟萃分析。
BMJ Open. 2020 Aug 16;10(8):e039652. doi: 10.1136/bmjopen-2020-039652.
6
Epidemiological Characteristics of COVID-19 Outbreak at Fitness Centers in Cheonan, Korea.韩国天安健身中心新冠疫情爆发的流行病学特征。
J Korean Med Sci. 2020 Aug 10;35(31):e288. doi: 10.3346/jkms.2020.35.e288.
7
Transmission onset distribution of COVID-19.COVID-19 的传播起始分布。
Int J Infect Dis. 2020 Oct;99:403-407. doi: 10.1016/j.ijid.2020.07.075. Epub 2020 Aug 6.
8
Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China.中国关于 2019 年冠状病毒病(COVID-19)发病前传播的证据。
Influenza Other Respir Viruses. 2021 Jan;15(1):19-26. doi: 10.1111/irv.12787. Epub 2020 Aug 7.
9
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.推断 SARS-CoV-2 的传染期:对无症状和有症状 COVID-19 病例的现有证据进行快速范围审查和分析。
BMJ Open. 2020 Aug 5;10(8):e039856. doi: 10.1136/bmjopen-2020-039856.
10
The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam.越南对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的前 100 天控制。
Clin Infect Dis. 2021 May 4;72(9):e334-e342. doi: 10.1093/cid/ciaa1130.